gentamicin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cornetta, K | 1 |
Moore, A | 1 |
Leemhuis, T | 1 |
Moen, RC | 1 |
Tricot, G | 1 |
Leibowitz, D | 1 |
Hoffman, R | 1 |
Cantin, A | 1 |
Woods, DE | 1 |
2 other studies available for gentamicin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Retroviral mediated gene transfer in chronic myelogenous leukaemia.
Topics: Base Sequence; Cytokines; Drug Resistance; Gene Transfer Techniques; Genetic Vectors; Gentamicins; H | 1994 |
Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.
Topics: Animals; Anti-Bacterial Agents; Catalase; Cats; Ceftazidime; Cell Survival; Dose-Response Relationsh | 1993 |